Who was Barbara Mitchell?
  1. pharmaceutical innovation
  2. pharmaceutical innovation

pharmaceutical innovation

Octobre 14, 2016 1:30AM

Intellectual Property Rights and the Promotion of Biologics, Medical Devices, and Trade in Pharmaceuticals
Steven Globerman, Kristina M.L. Acri, née Lybecker, Christopher Sands, Tomas J. Philipson
Printer-friendly version
Intellectual Property Rights and the Promotion of Biologics, Medical Devices, and Trade in Pharmaceuticals
Étiquettes:
intellectual property rights, intellectual property for pharmaceuticals, intellectual property protection, pharmaceutical innovation, biologics, pharmaceutical manufacture
Juillet 9, 2013 2:00AM

Trade and Economic Benefits of Enhanced Intellectual Property Protection for Pharmaceuticals in Canada
Nadeem Esmail, Kristina M.L. Acri, née Lybecker, Laura Dawson
Printer-friendly version
Étiquettes:
intellectual property, pharmaceuticals, intellectual property protection, CETA, pharmaceutical innovation, ip protection, trans-pacific partnership, TPP, trade benefits, economic benefits